FDA Adverse Event Injury Summary report: N

S-CATH M ESOPHAGEAL TEMPERATURE PROBE

MDR report key: 12178326 · Received July 15, 2021

Report

Report Number
3009437315-2021-00001
Event Type
Injury
Date Received
July 15, 2021
Date of Event
May 21, 2020
Report Date
July 15, 2021
Manufacturer
CIRCA SCIENTIFIC, INC.
Product Code
FLL
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

PROBE WAS DISCARDED BY THE HOSPITAL AFTER USE AND THEREFORE NO VISUAL INSPECTION OF THE COMPLAINT PROBE COULD BE PERFORMED. THE MANUFACTURER PERFORMED A REVIEW OF THE DEVICE HISTORY RECORDS, LABELLING AND EVALUATION OF A SAMPLE PROBE FROM RELEASED STOCK, ENGINEERING CHANGE REVIEW, DESIGN REVIEW AND COMMUNICATION WITH THE PHYSICIAN AND CIRCA SCIENTIFIC CLINICAL ADVISOR. THERE WAS NO IDENTIFIED LABELLING PROBLEM OR PRODUCT CHANGE OR DEFECT THAT WOULD ATTRIBUTE TO THE OESOPHAGEAL HAEMATOMA. REASON FOR HAEMATOMA IS INDETERMINATE AS IT MAY HAVE BEEN A COMBINATION OF OTHER PROCEDURE (TEE), PATIENT ANATOMY, AND UNKNOWN RESISTANCE DURING PROBE INSERTION.

Description of Event or Problem · 1

S-CATH M PROBE USED DURING ROUTINE PVI WITH MEDTRONIC ACHIEVE CRYO BALLOON. TEE PERFORMED PRE-PROCEDURE, WITH SORE THROAT REPORTED POST TEE, OTHERWISE UNREMARKABLE. IMMEDIATELY POST WAKING FROM PVI PATIENT REPORTED CHEST PAIN. DISMISSED INITIALLY AS TYPICAL POST PROCEDURE PAIN. ONE DAY POST PROCEDURE PATIENT CONTINUED TO REPORT CHEST PAIN WITH BLOOD IN STOOL AND REDUCED HAEMOGLOBIN. GASTROSCOPY PERFORMED SHOWING "LONG HEMI-CIRCUMFERENTIAL HAEMATOMA ! HALF THE LUMEN". PHYSICIAN REPORTED UNREMARKABLE CS-46EP PROBE INSERTION EXCEPT FOR POSSIBLY SOME RESISTANCE IN THE LAST ¼ OF INSERTION BUT NOTHING THAT WAS ALARMING. PROBE WAS DISCARDED AFTER CASE BEFORE ISSUE WAS IDENTIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1074529 S-CATH M ESOPHAGEAL TEMPERATURE PROBE ESOPHAGEAL TEMPERATURE PROBE FLL CIRCA SCIENTIFIC, INC. CS-46EP 12590-02

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization